These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8833831)

  • 1. A novel superantigenic exotoxin from Yersinia psuedotuberculosis and its position in the classification of the entire bacterial toxins.
    Uchiyama T
    Contrib Microbiol Immunol; 1995; 13():191-4. PubMed ID: 8833831
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research on superantigenic toxins integrating bacteriology, immunology, bacterial toxins, and clinical infections diseases].
    Uchiyama T
    Nihon Saikingaku Zasshi; 2002 Nov; 57(4):563-79. PubMed ID: 12518385
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for superantigen production by Yersinia pseudotuberculosis.
    Abe J; Takeda T; Watanabe Y; Nakao H; Kobayashi N; Leung DY; Kohsaka T
    J Immunol; 1993 Oct; 151(8):4183-8. PubMed ID: 8409395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and gene cloning of a superantigen (YPM) produced by a patient strain of Yersinia pseudotuberculosis.
    Takeda T; Yoshino K; Itoh Y; Abe J; Shimonishi Y; Kohsaka T
    Contrib Microbiol Immunol; 1995; 13():331-3. PubMed ID: 8833866
    [No Abstract]   [Full Text] [Related]  

  • 5. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms.
    Uchiyama T; Miyoshi-Akiyama T; Kato H; Fujimaki W; Imanishi K; Yan XJ
    J Immunol; 1993 Oct; 151(8):4407-13. PubMed ID: 8409410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a new type of invariant V alpha 14+ T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen.
    Yagi J; Dianzani U; Kato H; Okamoto T; Katsurada T; Buonfiglio D; Miyoshi-Akiyama T; Uchiyama T
    J Immunol; 1999 Sep; 163(6):3083-91. PubMed ID: 10477573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical role for a superantigen in Yersinia pseudotuberculosis infection.
    Abe J; Onimaru M; Matsumoto S; Noma S; Baba K; Ito Y; Kohsaka T; Takeda T
    J Clin Invest; 1997 Apr; 99(8):1823-30. PubMed ID: 9109426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The superantigenic toxin of Yersinia pseudotuberculosis: a novel virulence factor?
    Carnoy C; Müller-Alouf H; Desreumaux P; Mullet C; Grangette C; Simonet M
    Int J Med Microbiol; 2000 Oct; 290(4-5):477-82. PubMed ID: 11111929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporadic cases of Yersinia pseudotuberculosis serotype 5 infection in Shodo Island, Kagawa Prefecture.
    Sunahara C; Yamanaka Y; Yamanishi S
    Jpn J Infect Dis; 2000 Apr; 53(2):74-5. PubMed ID: 10871920
    [No Abstract]   [Full Text] [Related]  

  • 10. Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics.
    Welcher BC; Carra JH; DaSilva L; Hanson J; David CS; Aman MJ; Bavari S
    J Infect Dis; 2002 Aug; 186(4):501-10. PubMed ID: 12195377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generated single point-mutations can considerably dismantle the lymphocyte overstimulation induced by Yersinia pseudotuberculosis superantigen.
    Seprényi G; Ito Y; Kohsaka T
    Cell Immunol; 1999 Mar; 192(2):96-106. PubMed ID: 10087177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of T cells and gamma interferon in Yersinia pseudotuberculosis-derived mitogen (YPM)-induced toxicity in mice.
    Kano H; Ito Y; Matsuoka K; Iwata T; Saito H; Kohsaka T; Abe J
    Adv Exp Med Biol; 2003; 529():137-9. PubMed ID: 12756745
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of the superantigen-producing ability of Yersinia pseudotuberculosis strains of various serotypes isolated from patients with systemic or gastroenteric infections, wildlife animals and natural environments.
    Ueshiba H; Kato H; Miyoshi-Akiyama T; Tsubokura M; Nagano T; Kaneko S; Uchiyama T
    Zentralbl Bakteriol; 1998 Oct; 288(2):277-91. PubMed ID: 9809408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of T cell migration in bacterial superantigen-mediated shock in mice.
    Kano H; Ito Y; Matsuoka K; Nakajima T; Iwata T; Kohsaka T; Saito H; Abe J
    Clin Immunol; 2004 Feb; 110(2):159-71. PubMed ID: 15003813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are bacterial exotoxins cytokine network regulators?
    Henderson B; Wilson M; Wren B
    Trends Microbiol; 1997 Nov; 5(11):454-8. PubMed ID: 9402703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pathogenicity factors of Yersinia pseudotuberculosis and the pathogenetic aspects of pseudotuberculosis].
    Timchenko NF
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):25-9. PubMed ID: 9432840
    [No Abstract]   [Full Text] [Related]  

  • 17. [Yersinia pseudotuberculosis toxins].
    Timchenko NF
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):83-9. PubMed ID: 17163146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three outbreaks of yersinia pseudotuberculosis infection.
    Inoue M; Nakashima H; Ishida T; Tsubokura M
    Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1988 Aug; 186(5-6):504-11. PubMed ID: 3142167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Virulence of Yersinia pseudotuberculosis strains isolated from environment as a threat to human epidemic].
    Czyzewska I; Furowicz AJ
    Przegl Epidemiol; 2003; 57(2):263-70. PubMed ID: 12910593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial toxins and the immune system: show me the in vivo targets.
    Galán JE
    J Exp Med; 2005 Feb; 201(3):321-3. PubMed ID: 15699067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.